Company / Working Capital per Share
Edgewise Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.01
FY2025
5-year range
$4.87 / $7.28
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#110 of 210
Health Care
What the data says
At $5.01, Edgewise Therapeutics, Inc.'s working capital per share ranks #110 of 210 in the Health Care sector. Improved from $4.87 to $5.01 over the past 2 years.
Based on SEC 10-K filings.
5.01 in FY2025 with a 5-year CAGR of -50.6%.
Improved from $4.87 to $5.01 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -7.6%
- 5-Year CAGR
- -50.6%
- 10-Year CAGR
- -
Sector benchmark
#110 of 210 in Health CareTop 52% of 210This company $5.01 Sector average $118.60
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 2.6% year-over-year.
- Ranks #110 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.01 | +2.6% |
| FY2024 | $4.89 | +0.4% |
| FY2023 | $4.87 | -23.4% |
| FY2022 | $6.35 | -12.8% |
| FY2021 | $7.28 | -95.7% |
| FY2020 | $169.56 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026